TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing.

Autosomal-dominant spinocerebellar ataxias constitute a large, heterogeneous group of progressive neurodegenerative diseases with multiple types. To date, classical genetic studies have revealed 31 distinct genetic forms of spinocerebellar ataxias and identified 19 causative genes. Traditional positional cloning strategies, however, have limitations for finding causative genes of rare Mendelian disorders. Here, we used a combined strategy of exome sequencing and linkage analysis to identify a novel spinocerebellar ataxia causative gene, TGM6. We sequenced the whole exome of four patients in a Chinese four-generation spinocerebellar ataxia family and identified a missense mutation, c.1550T-G transition (L517W), in exon 10 of TGM6. This change is at a highly conserved position, is predicted to have a functional impact, and completely cosegregated with the phenotype. The exome results were validated using linkage analysis. The mutation we identified using exome sequencing was located in the same region (20p13-12.2) as that identified by linkage analysis, which cross-validated TGM6 as the causative spinocerebellar ataxia gene in this family. We also showed that the causative gene could be mapped by a combined method of linkage analysis and sequencing of one sample from the family. We further confirmed our finding by identifying another missense mutation c.980A-G transition (D327G) in exon seven of TGM6 in an additional spinocerebellar ataxia family, which also cosegregated with the phenotype. Both mutations were absent in 500 normal unaffected individuals of matched geographical ancestry. The finding of TGM6 as a novel causative gene of spinocerebellar ataxia illustrates whole-exome sequencing of affected individuals from one family as an effective and cost efficient method for mapping genes of rare Mendelian disorders and the use of linkage analysis and exome sequencing for further improving efficiency.

[1]  A. Dávalos,et al.  Cellular and Molecular Pathways Triggering Neurodegeneration in the Spinocerebellar Ataxias , 2010, The Cerebellum.

[2]  P. Plevani,et al.  Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28 , 2010, Nature Genetics.

[3]  E. Tongiorgi,et al.  Anti Transglutaminase Antibodies Cause Ataxia in Mice , 2010, PloS one.

[4]  Huanming Yang,et al.  De novo assembly of human genomes with massively parallel short read sequencing. , 2010, Genome research.

[5]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[6]  Yuko Saito,et al.  Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. , 2009, American journal of human genetics.

[7]  I. Tikhonova,et al.  Genetic diagnosis by whole exome capture and massively parallel DNA sequencing , 2009, Proceedings of the National Academy of Sciences.

[8]  Emily H Turner,et al.  Targeted Capture and Massively Parallel Sequencing of Twelve Human Exomes , 2009, Nature.

[9]  Arthur J. L. Cooper,et al.  Transglutaminase activation in neurodegenerative diseases. , 2009, Future neurology.

[10]  Mark A Horswill,et al.  Transglutaminases and neurodegeneration , 2009, Journal of neurochemistry.

[11]  Alan F. Scott,et al.  McKusick's Online Mendelian Inheritance in Man (OMIM®) , 2008, Nucleic Acids Res..

[12]  D. Sanders,et al.  Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase , 2008, Annals of neurology.

[13]  K. Kristiansen,et al.  SOAP: short oligonucleotide alignment program , 2008, Bioinform..

[14]  Markus Frings,et al.  Reliability and validity of the scale for the assessment and rating of ataxia: A study in 64 ataxia patients , 2007, Movement disorders : official journal of the Movement Disorder Society.

[15]  P L Pearson,et al.  Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3. , 2004, Brain : a journal of neurology.

[16]  Thorsten Schmidt,et al.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.

[17]  K. Xia,et al.  A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2L) maps to chromosome 12q24 , 2004, Human Genetics.

[18]  D. Aeschlimann,et al.  Evolution of Transglutaminase Genes: Identification of a Transglutaminase Gene Cluster on Human Chromosome 15q15 , 2001, The Journal of Biological Chemistry.

[19]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[20]  Soo-Youl Kim,et al.  Differential Expression of Multiple Transglutaminases in Human Brain , 1999, The Journal of Biological Chemistry.

[21]  M. Hallett,et al.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome , 1997, Journal of the Neurological Sciences.

[22]  G. Lathrop,et al.  Easy calculations of lod scores and genetic risks on small computers. , 1984, American journal of human genetics.

[23]  A. Harding CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.

[24]  Pask Ea,et al.  HOMOSEXUALITY AS A CRIME. , 1965 .

[25]  Osamu Onodera,et al.  Sporadic ataxias in Japan – a population-based epidemiological study , 2008, The Cerebellum.

[26]  D. Haussler,et al.  Human-mouse alignments with BLASTZ. , 2003, Genome research.